Not every country uses double-blind clinical trials to test the pharmaceuticals used. I seem to recall that the PRC was using spheramine treatments - what were their results? What about other countries? This might be purely a "local" problem of relying on a broken model (double blind clinical trials) all the while bolstering its reputation by proclaiming it to be a "gold standard".

Also, what happened to grounded research where the theory was grounded in the data rather than the data being derived against a specific theoretical background? Did grounded research get lost in the dust?